Summary
70 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 68 USD is left as net profit.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $15.0M in the last fiscal year, 28,940% of its market value.
- Revenue grew by 11% a year over the last 3 years.
What to watch
- It earns only 3.9 USD a year on every 100 USD of invested capital.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 0.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 7.5% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to grow by 8.0%.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 9.3 USD
- Research and development 14 USD
- Sales and administration 42 USD
- Taxes and other -33 USD
- Net profit 68 USD
Net profit, industry median (Medical - Pharmaceuticals) 5.0 USD
Out of every 100 USD of revenue, 68 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 8.6 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 4
- Sell 1
No analyst has published a price target.
58% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Royalty 28%
- Intangible Royalty Assets 24%
- Royalty, Kyprolis 9.8%
- Material Sales, Captisol 7.9%
- Material Sales, Captisol, Core 7.9%
- Other 22%
By region
The company reports no revenue by region.
Royalty brings in 28% of revenue.
Segments in detail